Nuevo estudio publicado en Clinical Cancer Research Journal destaca el uso de la prueba EndoPredict para informar el tratamiento en pacientes premenopáusicas con cáncer de mama
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
La prueba EndoPredict de Myriad Genetics identificó con precisión a mujeres premenopáusicas con cáncer de mama ER+, HER2- que podrían evitar la quimioterapia adyuvante de forma segura SALT LAKE CITY,...
Un nuovo studio pubblicato sulla rivista Clinical Cancer Research mette in evidenza l’impiego del test EndoPredict per indicare quale trattamento adottare in pazienti con tumore al seno in premenopausa
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
Il test EndoPredict di Myriad Genetics ha identificato in modo accurato le donne in premenopausa con carcinoma mammario ER+, HER2- che potevano con sicurezza evitare la chemioterapia adiuvante SALT...
Neue Studie, im Clinical Cancer Research Journal veröffentlicht, unterstreicht die Bedeutung des EndoPredict-Tests zur Information über die Behandlung von prämenopausalen Brustkrebs-Patientinnen
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict-Test identifiziert präzise prämenopausale Frauen mit ER+, HER2-Brustkrebs, die eine adjuvante Chemotherapie vermeiden können SALT LAKE CITY, Aug. 31, 2022 (GLOBE...
New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients
August 31, 2022 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 (GLOBE NEWSWIRE)...
GENE Momentum building - a year in review
August 30, 2022 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
Gene Amplification Technologies Global Market Report 2022: Advances in Genome Sequencing to Spur Industry Growth
August 25, 2022 06:28 ET
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Gene Amplification Technologies - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene...
Precipio Launches New 1-Step Technology for all HemeScreen Assays
August 16, 2022 11:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of its second generation of HemeScreen panels. Precipio’s...
Global Human Identification Market to Reach $6.43 Billion by 2032
August 04, 2022 05:43 ET
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "Human Identification - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and Forecast,...
Genetic Testing Global Market Report 2022:
August 02, 2022 05:58 ET
|
Research and Markets
Dublin, Aug. 02, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to...
Molecular Cytogenetics Global Market Report 2022-2026: Growing Demand for Targeted Therapies in Cancer Treatment Presents Lucrative Opportunities
July 29, 2022 06:03 ET
|
Research and Markets
Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Molecular...